Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis

M Mohammadi, H Zargartalebi, R Salahandish… - Biosensors and …, 2021 - Elsevier
Academic and industrial groups worldwide have reported technological advances in
exosome-based cancer diagnosis and prognosis. However, the potential translation of these …

The role of bone marrow mesenchymal stem cell derived extracellular vesicles (MSC-EVs) in normal and abnormal hematopoiesis and their therapeutic potential

AK Batsali, A Georgopoulou, I Mavroudi… - Journal of clinical …, 2020 - mdpi.com
Mesenchymal stem cells (MSCs) represent a heterogeneous cellular population responsible
for the support, maintenance, and regulation of normal hematopoietic stem cells (HSCs). In …

Umbilical mesenchymal stem cell-derived exosome-encapsulated hydrogels accelerate bone repair by enhancing angiogenesis

Y Zhang, Y Xie, Z Hao, P Zhou, P Wang… - … Applied Materials & …, 2021 - ACS Publications
Repair of large bone defects represents a major challenge for orthopedic surgeons. The
newly formed microvessels inside grafts play a crucial role in successful bone tissue …

Very small embryonic-like stem cells (VSELs) regenerate whereas mesenchymal stromal cells (MSCs) rejuvenate diseased reproductive tissues

D Bhartiya, P Singh, D Sharma, A Kaushik - Stem Cell Reviews and …, 2022 - Springer
Compared to embryonic and induced pluripotent stem cells, mesenchymal stem/stromal
cells (MSCs) have made their presence felt with good therapeutic promise and safety profile …

Mesenchymal stromal cells: role in the BM niche and in the support of hematopoietic stem cell transplantation

S Crippa, ME Bernardo - Hemasphere, 2018 - journals.lww.com
Mesenchymal stromal cells (MSCs) are key elements in the bone marrow (BM) niche where
they interact with hematopoietic stem progenitor cells (HSPCs) by offering physical support …

Engineering exosomes for bone defect repair

S Ma, Y Zhang, S Li, A Li, Y Li, D Pei - Frontiers in bioengineering …, 2022 - frontiersin.org
Currently, bone defect repair is still an intractable clinical problem. Numerous treatments
have been performed, but their clinical results are unsatisfactory. As a key element of cell …

MicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemia

S Trino, D Lamorte, A Caivano, I Laurenzana… - International journal of …, 2018 - mdpi.com
Acute myeloid leukemias (AML) are clonal disorders of hematopoietic progenitor cells which
are characterized by relevant heterogeneity in terms of phenotypic, genotypic, and clinical …

Mesenchymal stem cell–based therapy as a new approach for the treatment of systemic sclerosis

X Zhuang, X Hu, S Zhang, X Li, X Yuan… - Clinical reviews in allergy & …, 2022 - Springer
Systemic sclerosis (SSc) is an intractable autoimmune disease with unmet medical needs.
Conventional immunosuppressive therapies have modest efficacy and obvious side effects …

Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation

DP Sarvar, H Effatpanah, P Akbarzadehlaleh… - Stem Cell Research & …, 2022 - Springer
Bone marrow mesenchymal stromal cells (MSCs) play a crucial role in the regulation of
hematopoiesis. These cells affect the process through direct cell–cell contact, as well as …

Extracellular vesicles derived from umbilical cord mesenchymal stromal cells show enhanced anti-inflammatory properties via upregulation of miRNAs after pro …

M Hyland, C Mennan, R Davies, E Wilson… - Stem Cell Reviews and …, 2023 - Springer
Autoimmune conditions, such as rheumatoid arthritis, are characterised by a loss of immune
tolerance, whereby the immune cells attack self-antigens causing pain and inflammation …